Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Saturday, August 25, 2012
FDA readies for GDUFA-driven surge in supply chain data
Friday, August 24, 2012
Compounders Sent Letters Regarding Prascend (Pergolide)
IACP is reporting that it has become:
To read more information on the IACP website, click here
aware of letters being sent to compounders by Boehringer Ingelheim about their product Prascend (pergolide). The manufacturer cautions all pharmacists that any compounding of pergolide for veterinary use must only be done using their finished drug product and not the active pharmaceutical ingredient (API). If you’ve received that letter and want to know the specifics, contact us at iacpinfo@iacprx.org
To read more information on the IACP website, click here
Subscribe to:
Posts (Atom)